Sai Life Sciences announced a strategic collaboration with Mabtech, establishing its Boston lab as a US hub for the EYRA platform.

SL

Sai Life Sciences LimitedSAILIFE · Filed with the exchange

This enhances Sai's capabilities in advanced immunology assay services, strengthening its offerings for biopharma clients in immune profiling.

No comments yet. Be the first.

More from Sai Life Sciences Limited

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.